Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

NextEra Energy Stock (NEE) in Focus: AI Data Center Deals, 2026 Earnings Outlook, and Wall Street Price Targets — Dec. 20, 2025

NextEra Energy Stock (NEE) in Focus: AI Data Center Deals, 2026 Earnings Outlook, and Wall Street Price Targets — Dec. 20, 2025

NextEra Energy, Inc. (NYSE: NEE) is ending 2025 with a familiar role—and a new narrative. For years, investors have treated NextEra as a premium “growth utility,” built on Florida Power & Light’s regulated stability and NextEra Energy Resources’ renewables scale. In December, that story expanded into something broader: power for AI and hyperscale data centers—and the infrastructure required to deliver it reliably. As of Saturday, Dec. 20, 2025, U.S. equity markets are closed. NEE last traded at $79.54, reflecting Friday’s close. Stock Invest What’s driving attention now isn’t a single headline—it’s a cluster of announcements and analyst updates that, together,
Linde plc Stock (LIN) Today: Latest News, Analyst Forecasts and 2026 Outlook — December 20, 2025

Linde plc Stock (LIN) Today: Latest News, Analyst Forecasts and 2026 Outlook — December 20, 2025

Linde plc (Nasdaq: LIN) is ending the week near the $420 mark as investors weigh a familiar tug-of-war: resilient pricing and shareholder returns on one side, and softer industrial activity—especially in Europe—on the other. The latest close on Friday, December 19, 2025, was $421.43, up 0.58% on the day, after a choppy first half of December. StockAnalysis+1 What’s notable about today (Saturday, December 20) is less about a single breaking headline and more about how multiple recent threads are converging: a cautious near-term macro tone, an investor-event-driven debate about 2026 growth, fresh analyst target updates, and an insider purchase by
Booking Holdings (BKNG) Stock News, Forecasts, and Analysis for Dec. 20, 2025: Court Ruling Risk Meets Holiday Travel Tailwinds

Booking Holdings (BKNG) Stock News, Forecasts, and Analysis for Dec. 20, 2025: Court Ruling Risk Meets Holiday Travel Tailwinds

Booking Holdings Inc. (NASDAQ: BKNG) heads into the weekend of December 20, 2025 with investors balancing two powerful narratives: robust global travel demand and a fresh legal jolt in Europe tied to Booking.com’s historical “best price” (rate parity) clauses. As of the latest available U.S. market data (U.S. exchanges are closed on Saturday), BKNG last traded around $5,394, up roughly 0.95% from the prior close. Below is a roundup of the most relevant current news, forecasts, and market analysis shaping the Booking Holdings stock story as of 20.12.2025. BKNG stock snapshot: where Booking Holdings stands heading into the weekend BKNG
ON Semiconductor (ON) Stock: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 20, 2025

ON Semiconductor (ON) Stock: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 20, 2025

ON Semiconductor Corporation (onsemi) stock is ending 2025 with a dense stack of market-moving catalysts—ranging from fresh gallium nitride (GaN) partnerships and expanded automotive power-supply wins to a major European silicon carbide (SiC) investment tailwind and an upcoming Nasdaq-100 index removal. As of Dec. 20, 2025, ON Semiconductor (NASDAQ: ON) shares traded around $55.21. Below is what investors are watching right now, what Wall Street is forecasting, and how the near-term debate around ON stock is shaping up heading into 2026. ON Semiconductor stock is in focus for one big reason: catalysts are colliding Several developments are converging at once:
Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

December 20, 2025 — Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) heads into the year’s final stretch with investors focused on a familiar question: can the biotech’s next wave of launches and late-stage programs begin to meaningfully diversify a cystic fibrosis (CF) business that has dominated its revenue for more than a decade? VRTX shares most recently closed at $456.20 on Friday, Dec. 19, up 1.97% in that session. StockAnalysis Below is the current news, forecasts, and market analysis shaping Vertex stock as of Dec. 20, 2025, including the latest on Casgevy’s pediatric data, Journavx’s commercial ramp, and a kidney-disease pipeline that
Analog Devices (ADI) Stock News & Forecast: Wall Street Lifts Targets Up to $350 as AI Infrastructure and Industrial Recovery Drive 2026 Outlook (Dec. 20, 2025)

Analog Devices (ADI) Stock News & Forecast: Wall Street Lifts Targets Up to $350 as AI Infrastructure and Industrial Recovery Drive 2026 Outlook (Dec. 20, 2025)

Analog Devices, Inc. (NASDAQ: ADI) heads into the final stretch of 2025 with its stock trading near recent highs and analysts actively revising forecasts. As of December 20, 2025 (markets closed for the weekend), ADI shares were around $274.44, following Friday’s close. The past few days brought a cluster of fresh price-target hikes, new sell-side commentary on the AI infrastructure cycle, and new insider-trading filings—all against the backdrop of a strong fiscal Q4 report and an upbeat Q1 outlook that management says is supported by continued bookings strength and cyclical recovery. Reuters+1 What’s happening with Analog Devices stock right now
20 December 2025
SanDisk (SNDK) Stock: Today’s News, Analyst Targets, and Fresh 2026–2027 Forecasts (Dec. 20, 2025)

SanDisk (SNDK) Stock: Today’s News, Analyst Targets, and Fresh 2026–2027 Forecasts (Dec. 20, 2025)

SanDisk Corporation stock (Nasdaq: SNDK) heads into the weekend with momentum—and a growing debate over just how far the rally can go. As of Saturday, December 20, 2025, shares are indicated around $237.61, reflecting the last U.S. session’s move and a sharp gain versus the prior close. The latest catalyst is not an earnings report from SanDisk itself, but a sector-wide re-rating after peer Micron delivered a bullish outlook tied to AI-driven memory demand—an update that helped lift other memory names, including SanDisk, in the same breath. Reuters Below is a detailed roundup of what’s driving SanDisk stock now, what
Coca-Cola Stock (NYSE: KO) News, Forecasts, and Analyst Outlook on Dec. 20, 2025

Coca-Cola Stock (NYSE: KO) News, Forecasts, and Analyst Outlook on Dec. 20, 2025

As of Saturday, December 20, 2025, The Coca-Cola Company (NYSE: KO) is in the spotlight for a mix of leadership transition news, portfolio reshaping chatter, and fresh institutional/insider disclosures—all while the stock continues to trade like a classic consumer-staples “anchor” holding built on pricing power and dividends. With U.S. markets closed for the weekend, KO’s most recent regular-session action reflects Friday, Dec. 19, 2025 trading, when shares hovered around $70 and remained within striking distance of their 52-week high ($74.38)—a reminder that investors have continued to treat Coca-Cola as a defensive compounder even amid broader market volatility. markets.businessinsider.com Below is
Coinbase (COIN) Stock News Today (Dec. 20, 2025): “Everything Exchange” Push, Prediction-Market Lawsuits, and Wall Street Forecasts

Coinbase (COIN) Stock News Today (Dec. 20, 2025): “Everything Exchange” Push, Prediction-Market Lawsuits, and Wall Street Forecasts

Coinbase Global, Inc. (NASDAQ: COIN) is ending the week in the spotlight after a rapid sequence of catalysts reshaped the near-term narrative around the stock: a major product rollout that brings stock trading and prediction markets into the main Coinbase app, new legal fights over whether states can restrict those prediction markets, and fresh analyst coverage framing Coinbase’s ambition to become a multi-asset “everything exchange.” Investing.com+3Coinbase+3Reuters+3 On Saturday, December 20, 2025, U.S. markets are closed, but the latest available COIN quote sits around $245.12, up about 2.47% from the prior close (with an intraday range near $240.98–$247.19 and volume around
Biogen Stock (NASDAQ: BIIB) News and Forecasts for Dec. 20, 2025: RBC’s $210 Target, Leqembi Catalysts, and What Investors Are Watching

Biogen Stock (NASDAQ: BIIB) News and Forecasts for Dec. 20, 2025: RBC’s $210 Target, Leqembi Catalysts, and What Investors Are Watching

Biogen Inc. stock (NASDAQ: BIIB) is ending the week on a stronger note after a sharp, high-volume move on Friday’s session—an attention-grabbing setup heading into late December when liquidity often thins and headlines can move shares quickly. As of Saturday, December 20, 2025 (with U.S. markets closed), BIIB is effectively reflecting Friday, Dec. 19’s close of $174.80, up 2.88% on the day. Trading activity stood out: volume hit roughly 15.0 million shares, far above the recent ~1.9 million 50-day average—an unusual spike that often signals institutional participation rather than routine retail churn. MarketWatch+1 Below is a complete, publication-ready breakdown of
KLA Corporation Stock (KLAC): Today’s News, Analyst Forecasts, and 2026 Outlook as AI Drives Chip Equipment Spending (Dec. 20, 2025)

KLA Corporation Stock (KLAC): Today’s News, Analyst Forecasts, and 2026 Outlook as AI Drives Chip Equipment Spending (Dec. 20, 2025)

KLA Corporation (NASDAQ: KLAC) heads into the Dec. 20, 2025 weekend with its stock sitting near recent highs after a volatile mid-December stretch that featured a major analyst upgrade, multiple price-target increases, and fresh industry forecasts projecting another leg of growth in global chipmaking equipment demand. As of the most recent close (Friday, Dec. 19), KLAC ended at $1,245.67, up 1.90% on the day and close to its widely watched technical “buy point” levels cited by some market technicians. Investing.com+1 Below is a comprehensive, news-style breakdown of what’s moving KLA stock right now—covering the latest analyst calls, industry spending forecasts,
Carnival Corporation Stock (CCL) News: Dividend Returns, 2026 Outlook, Analyst Price Targets and Key Risks (Updated Dec. 20, 2025)

Carnival Corporation Stock (CCL) News: Dividend Returns, 2026 Outlook, Analyst Price Targets and Key Risks (Updated Dec. 20, 2025)

Carnival Corporation & plc (NYSE: CCL) stock is ending the week in the spotlight after a sharp post-earnings move fueled by two signals equity investors have been waiting for: a reinstated dividend and management guidance pointing to another year of profit growth. The rally followed Carnival’s fiscal fourth-quarter and full-year 2025 results (released Friday, Dec. 19), in which the cruise giant posted record revenue, record adjusted earnings, and an upgraded balance-sheet narrative—then capped it with a plan to streamline its dual-listed structure. PR Newswire+1 Below is a comprehensive look at the latest developments shaping Carnival Corporation stock as of Saturday,

Stock Market Today

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

7 February 2026
London, Feb 7, 2026, 08:20 GMT — Market closed. London Stock Exchange Group plc (LSEG.L) shares ended Friday at 7,502 pence, down about 1.1% on the day, with London markets shut for the weekend and set to reopen on Monday. (MarketWatch) The stock has been caught in a wider repricing of software, data and analytics names as investors question which business models benefit from the next wave of AI — and which get squeezed. “It’s a de-risking trade,” Andrew Wells, chief investment officer at SanJac Alpha, said, as he argued the AI build-out had become “too pricey.” (Reuters) LSEG also
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop